Where Iovance Biotherapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the last quarter, 8 analysts rated Iovance Biotherapeutics (NASDAQ:IOVA) with an average price target of $24.25, a 21.25% increase from the previous average of $20. The current price of IOVA is $7.55, implying an upside potential.
May 30, 2023 | 12:04 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Iovance Biotherapeutics (NASDAQ:IOVA) has an average price target of $24.25 from 8 analysts, indicating a potential upside from its current price of $7.55.
The average price target of $24.25 from 8 analysts suggests a significant upside potential for IOVA. The increase in the average price target by 21.25% from the previous average indicates growing optimism among analysts. This positive sentiment is likely to have a short-term positive impact on the stock price.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100